SC 13G
REGENERON PHARMACEUTICALS, INC.
- Company
- REGENERON PHARMACEUTICALS, INC.
- Filed
- February 7, 2012
- Accession Number
- 0001193125-12-042488
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →